This is a pooled fund: many plans invest in it, and it holds the underlying securities.
This filing is a Direct Filing Entity (DFE) — a master trust or collective investment trust that pools assets from multiple participating plans. It does not have plan participants of its own, and the Plan Health Score formula doesn’t apply. Individual participant-facing plans that invest in this trust are the appropriate target for fiduciary analysis.
Cited interest vs pooled assets: cited interest sums what each participating plan reported holding in this trust, measured at that plan’s own year-end — and those filings span different years. Pooled assets is this single filing’s balance at one date. They’re independent measurements, so cited interest can land slightly above or below the pooled balance and won’t reconcile exactly.
Why no Schedule of Assets here? DFE holdings often live on the master trust’s own audited statement, not as a 4i schedule on the participating plans’ filings. We’re extending the parsing pipeline to cover DFE filings — see Methodology.
| Name | EIN | Location | Relation | Direct comp | Indirect comp |
|---|---|---|---|---|---|
| ADAMS STREET PARTNERS LP | 36-4395128 | — | NONE | $463K | — |
| KPMG LLP | 13-5565207 | — | NONE | $88K | — |
| T. ROWE PRICE ASSOCIATES, INC. | 52-0556948 | — | NONE | $51K | — |
| MAPLES AND CALDER | — | — | NONE | $27K | — |
| JP MORGAN CHASE BANK | 13-4994650 | — | NONE | $8K | — |
| PI | Investment | Type | Shares / units | Cost | Current value | % of plan |
|---|---|---|---|---|---|---|
| JPMorgan US Government Money Market Fund | — | — | $11.8M | $11.8M | 10.2% | |
| IDG China Venture Capital Fund IV | — | — | $5.8M | $10.3M | 8.9% | |
| Matrix Partners China III | — | — | $8.0M | $10.1M | 8.7% | |
| Banyan Capital Fund II | — | — | $1.2M | $8.4M | 7.2% |
| ChrysCapital Fund VII | — | — | $4.3M | $8.3M | 7.1% |
| Da Vinci Private Equity II | — | — | $6.4M | $6.9M | 6.0% |
| RPEV I-B | — | — | $1.8M | $6.6M | 5.7% |
| Ascendent Capital Partners II | — | — | $5.6M | $6.1M | 5.2% |
| GC Equity Partners Fund III | — | — | $4.2M | $5.8M | 5.0% |
| Bain Capital Asia Fund III | — | — | $4.8M | $5.4M | 4.7% |
| Baring Vostok Private Equity Fund V LP | — | — | $3.8M | $5.1M | 4.4% |
| Turkish Private Equity Fund III | — | — | $3.6M | $4.3M | 3.7% |
| LC Fund VI | — | — | $4.0M | $4.3M | 3.7% |
| Item 4i - Schedule of Assets (Held At End of Year) Subheader Investments Cost Fair Value Advantech Capital | — | — | $2.1M | $4.0M | 3.4% |
| CVC Capital Partners Asia Pacific IV | — | — | $2.8M | $3.4M | 2.9% |
| Casrev Fund II 20 | — | — | — | $3.0M | 2.6% |
| Capitalworks Private Equity Fund II | — | — | $2.8M | $2.9M | 2.5% |
| CMC Capital Partners | — | — | $2.0M | $2.2M | 1.9% |
| CDH China Fund V | — | — | $2.2M | $1.4M | 1.2% |
| KV Asia Capital Fund I 0 | — | — | — | $1.3M | 1.1% |
| Boyu Capital Fund II | — | — | $1.4M | $1.2M | 1.0% |
| Monashees Capital VI | — | — | $996K | $1.2M | 1.0% |
| Baring Vostok Fund V Supplemental Fund | — | — | $2.1M | $1.1M | 0.9% |
| Redview Capital | — | — | $2.0M | $1.0M | 0.9% |
| First Collection Bureau | — | — | — | $222K | 0.2% |
| L Capital Asia I | — | — | $193K | $46K | <0.1% |
| ChrysCapital VI 0 | — | — | — | $5K | <0.1% |
| Ethos U.S. Dollar Fund V-B | — | — | $944K | $4K | <0.1% |
